Table 4 Duration and total costs for all community-acquired RV-GE induced hospital stays in the study hospital
Age | Pre-vaccination period (2002–2005) | Funded vaccination period (2008–2009) | Reduction | |||
|---|---|---|---|---|---|---|
Duration of hospital stay (days) per year (mean; 95% CI) | Estimated mean of total costs per year (for patients/accompanying persons) | Duration of hospital stay (days) per year (mean; 95% CI) | Estimated mean total costs per year (patient/accompanying person) | Duration of hospital stay decreased by (%) | Costs per year decreased by (%) | |
0–11 mos | 3.4 (3.1–3.7) | 224,216 €/ 7,865 € | 3.0 (2.3–3.6) | 29,295 €/ 1,087 € | 11.8 | 86.9/86.2 |
12–23 mos | 4.0 (3.6–4.3) | 242,904 €/ 8,521 € | 3.5 (3.4–3.5) | 86,256 €/ 3,201 € | 12.5 | 64.5/62.4 |
2–5 yrs | 3.7 (3.6–3.9) | 188,312 €/ 6,608 € | 3.5 (3.1–3.8) | 76,493 €/ 2,838 € | 5.4 | 59.4/57.1 |
6–10 yrs | 4.1 (3.7–4.4) | 63,493 €/0 | 2.5 (1.8–3.2) | 6,975 €/0 | 39.0 | - |
11–18 yrs | 3.9 (2.8–4.9) | 28,162 €/0 | 3.8 (2.7–4.8) | 5,301 €/0 | 2.6 | - |
All | 3.8 (3.5–4.1) | 747,087 €/22,994 € | 3.3 (2.7–3.8) | 204,320 €/ 7,126 € | 13.2 | 72.7/69.0 |